|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Cell Biology and Neuroscience, University of California, Riverside, CA, USA
2 Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
3 Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
4 Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
* To whom correspondence should be addressed. E-mail: zidovet{at}mail.ucr.edu.
We have observed that the vasoactive peptide endothelin-1 is a potent inducer of migration of primary human brain-derived microvascular endothelial cells. By blocking signal transduction pathways with specific inhibitors, and dominant negative mutant infections, we demonstrated that multiple pathways are involved in endothelin-1-induced migration. Absolutely required for migration are protein tyrosine kinase Src, Ras, protein kinase C, PI3-K, ERK and JNK; partial requirements were exhibited by cAMP-activated protein kinase and p38 kinase. Partial elucidation of the signal transduction sequences showed that the MAP kinases ERK, JNK, and p38 are positioned downstream of both protein kinase C and cAMP-activated protein kinase in the signal transduction scheme. The results show that human brain endothelial cell migration has distinct characteristics, different from cells derived from other vascular beds, or from other species, often used as model systems. Furthermore, the results indicate that endothelin-1, secreted by many tumors, is an important contributor to tumor-produced pro-angiogenic microenvironment. This growth factor has been associated with increased microvessel density in tumors, and responsible for endothelial cell proliferation, migration, invasion and tubule formation. Since many signal transduction pathways investigated in this study are potential or current targets for anti-angiogenesis therapy, these results are of critical importance for designing physiological anti-angiogenic protocols.
This article has been cited by other articles:
![]() |
A. Yogi, G.E. Callera, A.C.I. Montezano, A.B. Aranha, R.C. Tostes, E.L. Schiffrin, and R.M. Touyz Endothelin-1, but not Ang II, Activates MAP Kinases Through c-Src-Independent Ras-Raf-Dependent Pathways in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1960 - 1967. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |